- More Data Suggests New Coronavirus Variants Weaken Vaccines, Treatments
- Moderna COVID Vaccine Can Sometimes Trigger Delayed Skin Reactions
- Perils of the Pandemic: Scooters, Cleansers and Button Batteries
- American Indians Face the Highest Odds for Stroke
- COVID Leaves Most Pro Athletes With No Lasting Heart Damage: Study
- AHA News: Bypass Surgery Turned Doctor From Couch Potato Into Mountain Climber
- U.S. Hispanics at High Heart Disease Risk and Many Go Untreated: Report
- Catnip Might Be Your Next Mosquito Repellent
- COVID Death Rates 10 Times Higher in Countries Where Most Are Overweight: Report
- Health Highlights: March 4, 2021
Clinical Trials Update: April 27, 2010
Here are the latest clinical trials, courtesy of ClinicalConnection.com:
Crohn’s Disease
This study will evaluate an investigational medication for Crohn’s disease. You must be 18 or older and have mild-to-moderate active Crohn’s to qualify.
The research study is in Raleigh, N.C.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/crohn’s_disease.aspx.
—–
Type 2 Diabetes
This study will evaluate an investigational drug. Candidates must be at least 18 and have type 2 diabetes that is inadequately controlled with oral medication.
The research site is in Phoenix, Ariz.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/diabetes.aspx.
—–
Ulcerative Proctitis
To qualify for this study, you must be 18 or older and have symptoms of ulcerative proctitis, which may include frequent bowel movements, diarrhea, bloody stools, or abdominal discomfort.
The research site is in New York City.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/proctitis.aspx.
—–
Copyright 2010 ClinicalConnection.com. All rights reserved.
Source: HealthDay
